Shopping Cart
Remove All
Your shopping cart is currently empty
Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $619 | In Stock | In Stock | |
| 10 mg | $877 | - | In Stock | |
| 25 mg | $1,280 | - | In Stock | |
| 50 mg | $1,750 | - | In Stock | |
| 100 mg | $2,360 | - | In Stock |
| Description | Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers. |
| Synonyms | JNJ-61610588 |
| Reactivity | Human |
| Verified Activity | Immobilized TARGET at 2 μg/mL (30 μL/well) can bind Anti-B7-H5 / VISTA Reference Antibody (onvatilimab) with the EC50 of 15.13 ng/mL. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 144.52 kDa |
| Cas No. | 1969313-51-6 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.